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Abstract
Introduction:  Renal cell carcinoma (RCC) accounts for 3% of all adult tumors. The mainstay of treatment of
RCCs in the past has remained radical nephrectomy (RN). Studies have found a higher cumulative incidence
of development of chronic renal insufficiency in patients undergoing RN for RCC.
Objectives:  To determine the frequency of decrease in 24-h urinary creatinine clearance (CrCl) as an
indicator of functional decline after nephrectomy for RCC.
Subjects  and  methods:  A total of 103 patients of RCC undergoing RN were included in the study. Patients’
24-h urinary CrCls were measured pre-nephrectomy and 3 months post-nephrectomy. The patients’ demo-
graphic and tumor characteristics were noted from case files. Data was analyzed by using SPSS version
15.0.
Results: There were 61 (59.2%) males and 42 (40.8%) females with a mean age of 60.12 ±  8.88 years.
The mean maximum tumor diameter was 8.5 ±  2.6 cm. The mean preoperative serum creatinine in
the study group was 1.01 ±  0.24 mg/dl, while the mean 3-month postoperative serum creatinine was
1.29 ±  0.46 mg/dl. The mean preoperative CrCl measured in this study was 112.02 ±  6.04 ml/min/1.73 m2,
while the 3-month postoperative value was 102.94 ±  14.10 ml/min/1.73 m2, a mean decrease of
9.08 ml/min/1.73 m2. The decrease in CrCl was identified in 34 (33%) patients. No association was found
between the measured functional decline and the patients’ age and gender and stage of the disease.
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Conclusion:  The results from this study show that RN is associated with a decrease in CrCl in one third of
the study population. Therefore it is recommended that patients undergoing RN should be strictly monitored
for occult renal failure and managed promptly to prevent serious morbidity of frank renal failure.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
Introduction
Renal cell carcinoma (RCC) accounts for 3% of all adult solid
tumors, with the highest incidence between 50 and 70 years of age
[1,2]. With advances in radiological tools, such as ultrasound, mag-
netic resonance imaging (MRI) and computed tomography (CT), an
increase in the detection rate of up to 40% of incidental small renal
masses has been noted [3]. Radical nephrectomy (RN) has remained
the cornerstone of therapy for RCC for many years. This was based
on the presumption by most urologists that RN provided the excel-
lent cancer control with little effect on the overall renal function.
Most of the functional studies in the past used either serum creati-
nine or calculated or estimated glomerular filtration rate (eGFR) for
measurement of the kidney function. Studies conducted in the recent
past have shown that the renal functional outcome after nephrec-
tomy, using serum creatinine and eGFR has underestimated the true
impact on the renal function [4–7]. A recent study has shown a sig-
nificantly greater decline in renal function post-RN of about 31.6%
by measuring 24-h urinary creatinine clearance (CrCl) [8].
Studies have also found a higher cumulative incidence of develop-
ment of chronic renal insufficiency in patients who have undergone
RN [5,9]. These findings are significant as chronic renal insuf-
ficiency is associated with complications such as hypertension,
anemia, malnutrition and reduced quality of life, in addition to an
increased risk of cardiovascular disease and mortality [10–16].
In Pakistan, no study has been published till date, estimating the
decline of renal function post-nephrectomy, especially post-RN. In
this study, we studied the frequency of decrease in renal function by
using 24-h CrCl in post-tumor nephrectomy so that early measures
could be taken to minimize the degree of chronic renal insufficiency
after tumor nephrectomy.
Subjects  and  methods
The study was conducted in the Adult Urology Department of Sindh
Institute of Urology and Transplantation (SIUT), Karachi, Pakistan.
It was a prospective cohort study. Patients’ data were evaluated from
July 2012 to January 2013. Patients of either gender, ≥18 years of
age, diagnosed as RCC, on the basis of arterial enhancement on
CT scan, of any stage and duration of disease were included in
this study. Patients with solitary kidney, renal stones or co-morbids
like diabetes and hypertension were excluded from this study to
avoid bias. Written informed consent was obtained prior to the
nephrectomy and for inclusion in the study. The study was con-
ducted according to the tenets of Declaration of Helsinki and was
approved by the ethical review committee of the institute. The demo-
graphic and tumor characteristics were retrieved from the case files
of patients. Patients’ 24-h CrCl was measured before and 3 months
post-nephrectomy according to standard methodology [8]. Renal
function was also assessed by measuring serum creatinine and eGFR
using chronic kidney disease (CKD) epidemiology collaboration
(CKD-epi) formula as a comparator [17].
Data  analysis
The software program statistical package for social sciences (SPSS)
for Windows version 15.0 (SPSS Inc., Chicago, Illinois, USA) was
utilized for all statistical analysis. Mean ±  standard deviation (SD)
were computed for continuous variables like age and duration of
disease. Numbers and percentages were used to summarize the cat-
egorical variables like gender distribution, stage of disease and final
outcome (decrease in CrCl). Stratification of data was done for age,
gender, duration and the stage of disease with final outcome. The
chi-square test was applied to see the association of these with the
outcome variable. p  < 0.05 was considered as significant.
Results
Between July 2012 and January 2013, 103 patients with RCC were
identified who fulfilled the study inclusion criteria and were treated
by RN approach. All patients were assessed for 24-h urinary CrCl
before and 3 months after nephrectomy, which formed the main
study variable. A decrease in the measured CrCl was the main
outcome variable in the study.
The mean age of patients was 60.12 ±  8.88 years and the range was
between 50 and 79 years. Sixty seven patients (65%) patients were
aged ≤60 years while 36 (35%) were aged >60 years. Sixty-one
(59.2%) patients were males, 42 (40.8%) females with the male to
female ratio of 1.45:1, as shown in Table 1.
The mean maximum tumor dimension was 8.5 ±  2.6 cm. Sixty
patients had a RCC of stage 2 or less, accounting for 58.3% of
the study group. The rest of the 43 participants had stage 3 or higher
disease, representing 41.7% of the study population. In this study,
54 of the study participants had disease duration of ≤6 months
Table  1  Patients demographic and tumor characteristics.
Total number of patients 103
Males 61 (59.2%)
Females 42 (40.8%)
Male to female ratio 1.4:1
Mean age (in years) 60.12 ± 8.88
Age range (in years) 50–79
Disease duration (in months) 5.58 ± 3.11
Mean maximum diameter of tumors, cm 8.5 ± 2.6
Pathologic stage of disease ≤2 60 (58.3%)
Pathologic stage of disease >2 43 (41.7%)
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making up 52.4% of the population. The rest of the 49 patients
(47.6%) of the group had disease duration of >6 months.
The mean preoperative creatinine levels in this study group
were observed to be 1.01 ±  0.24 mg/dl, while the mean post-
operative value was 1.29 ±  0.46 mg/dl. The mean preoperative
CrCl calculated in this study was 112.02 ±  6.04 ml/min/1.73 m2,
while the postoperative value was calculated to be 102.94 ±
14.10 ml/min/1.73 m2. This resulted in a mean decline in measured
CrCl of 9.08 ml/min/1.73 m2. The final outcome of this study, i.e.,
decrease in CrCl, was observed in 34 (33%) of the patients.
No association was found between the measured functional decline
and the patients’ age (p  value = 0.95), and gender (p  value = 0.22)
and stage (p  value = 0.93) of the disease.
The mean preoperative eGFR was 96 ±  31 ml/min/1.73 m2 while the
mean postoperative eGFR at 3 months was 87 ±  26 ml/min/1.73 m2.
Thus, the renal functional assessment by calculated eGFR also com-
plimented the findings of 24-h urinary CrCl.
Discussion
RN is considered the standard surgical approach for renal cell can-
cer. The CrCl measured by 24-h urine collection is considered as
a standard test to assess renal function of the solitary kidney post-
surgery. Improper urine collection is one of the factors that can
affect the final result; nonetheless, this method is commonly used
in many clinical centers and hospitals to investigate renal function.
The results of the current study revealed that among the patients who
underwent nephrectomy for RCC, 33% showed decreased CrCl.
RCC is a kidney cancer that originates from the lining of the prox-
imal convoluted tubules. RCC accounts for approximately 3% of
adult malignancies and 80% of neoplasms arising from the kidney
[1,2]. Majority of the patients belong to old age group and male
gender worldwide [3]. In this study, the majority of the patients
belonged to ≤60 years age group (mean age of 60.12 years), with a
male predominance (59.2%), with male to female ratio being 1.45:1.
Out of 172 study patients, Shirasaki et al. encountered 124 (72.09%)
males and 48 (27.9%) females with a mean age of 59.4 years, in their
clinical study which is comparable to the results in this study [16].
Contrary to the observations made in this study, a recent study con-
ducted in 2011 showed majority of the patients as females (69.4%)
[18].
The treatment options for RCC are surgery, radiation therapy,
chemotherapy, hormonal therapy, immunotherapy, or a combination
of the above modalities. Among these, surgery remains the mainstay
of treatment in terms of prognosis, ranging from partial (nephron-
sparing), where possible, to RN depending upon the stage of disease
[19]. In this study, majority of patients (58.3%) had ≤2 stage dis-
ease and all of them underwent RN. Generally, the widely accepted
indications for nephron-sparing surgery (NSS) include tumor in a
solitary kidney, bilateral renal tumors or a contralateral kidney at
risk of medical disorder [16].
NSS allows maximal parenchymal preservation in cases of small
renal tumors, especially those less than 4 cm in diameter. There is
significantly less deterioration in total renal function in patients who
are treated with partial nephrectomy than those who are treated by
RN [6,7]. It has been found that NSS is better than RN in preserving
renal function even in extended warm ischemia times [13]. However,
NSS still remains a grossly underutilized procedure for the treatment
of renal tumors [8].
In the present study, 33% of patients exhibited decreased CrCl val-
ues after 3 months of nephrectomy, similar to previous reports, and
it appears that RN has significant disadvantage on renal function.
Clark et al. conducted a comparative study between partial and RN
on 63 patients and observed significant postoperative change in CrCl
in the RN group (31.6%) in comparison to partial nephrectomy
group (6.1%) concluding that there is a significant deterioration
in the overall renal function of patients who are treated with RN
[8]. Similarly, Shiraski and colleagues in their prospective study to
evaluate renal function post-nephrectomy too observed a number of
patients having deteriorating renal functions after the surgical pro-
cedure, with 3.5% of their study population requiring hemodialysis
due to poor renal functioning after nephrectomy [16].
The risk of worsening or development of de novo medical renal
disease in the contralateral kidney must be considered in patients
with RCC who undergo surgical removal as the primary mode
of therapy. The preoperative elevated serum creatinine levels and
decreased CrCls are the most important predictive factors for post-
operative kidney function deterioration and are useful for screening
patients who are likely to develop abnormal renal function post-
nephrectomy. In such conditions, NSS can be considered nearly
imperative or a relative indication in order to avoid decreases renal
function [18–21].
There are certain limitations in the study too. We included only
those patients who underwent RN. No comparison was made with
partial nephrectomy cases, as very few partial nephrectomies are
done in our set up. Renal function was measured only once after
nephrectomy at 3 months. The inherent problems of compliance
in 24-h urinary collection cannot be entirely excluded. We used
only measured CrCl and serum creatinine as the surrogate markers
of renal function and not the inulin or radionuclide based assays,
which are much more sensitive and accurate. We also did not include
patients with co-morbids such as diabetes mellitus and hypertension,
which might affect the rate and degree of functional decline. Our
results cannot therefore be generalized to all patients. We also did not
evaluate the split renal function of both kidneys; rather we used only
total renal function. Nevertheless, it is the first study from Pakistan
examining the effect of RN on the kidney function in the short term.
More studies with larger samples and prolonged follow-up with
serial determinations of renal functions are needed to validate the
results of the present study.
Conclusion
In conclusion, the results from this study show that RN is associated
with a decrease in CrCl in 33% of the study population. Therefore,
it is recommended that patients undergoing RN should be strictly
monitored for occult renal failure and managed promptly to prevent
serious morbidity of frank renal failure.
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